PUBLISHER: IMARC | PRODUCT CODE: 1467570
PUBLISHER: IMARC | PRODUCT CODE: 1467570
Precision Psychiatry Market Report by Product Type, Sample, Biomarker Type, Technology, Application, End User, and Region 2024-2032
The global precision psychiatry market size reached US$ 1,059.7 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 4,027.9 Million by 2032, exhibiting a growth rate (CAGR) of 15.5% during 2024-2032. The rising prevalence of mental health disorders among the masses, the growing need for personalized treatment plans and interventions and the advent of genetic testing, and data analytics represent some of the key factors driving the market.
Precision psychiatry refers to an innovative medical approach that is widely adopted for mental health care. It leverages numerous advanced technologies and personalized medicine to provide more targeted and effective treatments for individuals suffering from psychiatric disorders. It recognizes that mental illnesses, such as depression, anxiety, bipolar disorder, and schizophrenia, are complex and multifaceted conditions influenced by a combination of genetic, environmental, and lifestyle factors. It aims to tailor multiple interventions based on an individual's unique characteristics, including their genetic makeup, neurobiological markers, and personal circumstances. It allows clinicians to gain deeper insights into the underlying mechanisms of psychiatric disorders and develop personalized treatment plans accordingly. Besides this, it also identifies specific genetic variations that may contribute to the susceptibility to certain mental health conditions or influence the response to particular medications. This information allows for the selection of more appropriate and targeted treatment options, increasing the likelihood of positive outcomes while minimizing the potential for adverse effects.
Precision Psychiatry Market Trends:
The global market is majorly driven by the rising prevalence of mental health disorders among the masses. Coupled with the growing need for personalized treatment plans and interventions, there has been a considerable increase in the adoption of precision psychiatry among individuals. Since precision psychiatry aligns with the broader trend toward personalized medicine across various medical fields. It recognizes that each individual is unique and requires tailored treatments based on their genetic, neurobiological, and environmental factors. This personalized approach resonates with patients, as it offers the prospect of more effective treatments and improved outcomes, which is gaining widespread prominence among the masses. Moreover, continual technological advancements, such as the advent of genetic testing, neuroimaging, and data analytics have significantly contributed to the development and implementation of precision psychiatry, further impacting the market favorably. Apart from this, the growing interest in precision psychiatry is accompanied by rising research activities and funding support. Academic institutions, research organizations, and pharmaceutical companies are investing in research to better understand the biological mechanisms of psychiatric disorders and develop targeted treatments, hence providing an impetus to the market. Other factors, including rapid urbanization, growing awareness among individuals and continual developments in the healthcare infrastructure, are also positively influencing the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global precision psychiatry market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, sample, biomarker type, technology, application, and end user.
Product Type Insights:
Products
Services
The report has provided a detailed breakup and analysis of the precision psychiatry market based on the product type. This includes products and services. According to the report, products represented the largest segment.
Sample Insights:
Blood-Based
Non-Blood-Based
Saliva
Urine
Cerebral Spinal Fluid (CSF)
Others
A detailed breakup and analysis of the precision psychiatry market based on the sample has also been provided in the report. This includes blood-based and non-blood-based (saliva, urine, cerebral spinal fluid (CSF), and others). According to the report, non-blood-based accounted for the largest market share.
Biomarker Type Insights:
Genetic Biomarker
Protein Biomarker
The report has provided a detailed breakup and analysis of the precision psychiatry market based on the biomarker type. This includes genetic biomarker and protein biomarker. According to the report, protein biomarker exhibits a clear dominance in the market.
Technology Insights:
Sequencing
Next-Generation Sequencing (NGS)
Sanger Sequencing
Polymerase Chain Reaction (PCR)
Real-Time Polymerase Chain Reaction (RT-PCR)
Digital Polymerase Chain Reaction (dPCR)
Microarray
Immunoassay
Liquid Chromatography-Mass Spectrometry (LC-MS)
Others
The report has provided a detailed breakup and analysis of the precision psychiatry market based on the technology. This includes sequencing [next-generation sequencing (NGS) and sanger sequencing], polymerase chain reaction (PCR) [real-time polymerase chain reaction (RT-PCR) and digital polymerase chain reaction (dPCR)], microarray, immunoassay, liquid chromatography-mass spectrometry (LC-MS), and others. According to the report, sequencing represented the largest segment.
Application Insights:
Alzheimer's Disease
Parkinson's Disease
Autism
Depression
Bipolar Disease
Others
A detailed breakup and analysis of the precision psychiatry market based on the application has also been provided in the report. This includes Alzheimer's disease, Parkinson's disease, autism, depression, bipolar disease, and others. According to the report, depression accounted for the largest market share.
End User Insights:
Hospitals and Diagnostic Laboratories
Academic and Research Institutions
Others
The report has provided a detailed breakup and analysis of the precision psychiatry market based on the end user. This includes hospitals and diagnostic laboratories, academic and research institutions and others. According to the report, hospitals and diagnostic laboratories exhibits a clear dominance in the market.
Regional Insights:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for precision psychiatry. Some of the factors driving the North America precision psychiatry market included the growing awareness among the masses, the emerging healthcare industry, the shifting lifestyle preferences of the masses, etc.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global precision psychiatry market. Detailed profiles of all major companies have been provided. Some of the companies covered include Altimate Healthcare, Alto Nanoscience, ATAI Life Sciences N.V., Fulgent Genetics Inc, Invitae Corporation, Myriad Genetics Inc., Precision Psychiatric Services Inc., Tempus Labs Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global precision psychiatry market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global precision psychiatry market?
- What is the impact of each driver, restraint, and opportunity on the global precision psychiatry market?
- What are the key regional markets?
- Which countries represent the most attractive precision psychiatry market?
- What is the breakup of the market based on the product type?
- Which is the most attractive product type in the precision psychiatry market?
- What is the breakup of the market based on the sample?
- Which is the most attractive sample in the precision psychiatry market?
- What is the breakup of the market based on the biomarker type?
- Which is the most attractive biomarker type in the precision psychiatry market?
- What is the breakup of the market based on technology?
- Which is the most attractive technology in the precision psychiatry market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the precision psychiatry market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the precision psychiatry market?
- What is the competitive structure of the global precision psychiatry market?
- Who are the key players/companies in the global precision psychiatry market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Precision Psychiatry Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Products
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Services
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Sample
- 7.1 Blood-Based
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Non-Blood-Based
- 7.2.1 Market Trends
- 7.2.2 Key Segments
- 7.2.2.1 Saliva
- 7.2.2.2 Urine
- 7.2.2.3 Cerebral Spinal Fluid (CSF)
- 7.2.2.4 Others
- 7.2.3 Market Forecast
8 Market Breakup by Biomarker Type
- 8.1 Genetic Biomarker
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Protein Biomarker
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Technology
- 9.1 Sequencing
- 9.1.1 Market Trends
- 9.2.2 Key Segments
- 9.2.2.1 Next-Generation Sequencing (NGS)
- 9.2.2.2 Sanger Sequencing
- 9.1.3 Market Forecast
- 9.2 Polymerase Chain Reaction (PCR)
- 9.2.1 Market Trends
- 9.2.2 Key Segments
- 9.2.2.1 Real-Time Polymerase Chain Reaction (RT-PCR)
- 9.2.2.2 Digital Polymerase Chain Reaction (dPCR)
- 9.2.3 Market Forecast
- 9.3 Microarray
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Immunoassay
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Liquid Chromatography-Mass Spectrometry (LC-MS)
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
- 9.6 Others
- 9.6.1 Market Trends
- 9.6.2 Market Forecast
10 Market Breakup by Application
- 10.1 Alzheimer's Disease
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Parkinson's Disease
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Autism
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Depression
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
- 10.5 Bipolar Disease
- 10.5.1 Market Trends
- 10.5.2 Market Forecast
- 10.6 Others
- 10.6.1 Market Trends
- 10.6.2 Market Forecast
11 Market Breakup by End User
- 11.1 Hospitals and Diagnostic Laboratories
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
- 11.2 Academic and Research Institutions
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
- 11.3 Others
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
12 Market Breakup by Region
- 12.1 North America
- 12.1.1 United States
- 12.1.1.1 Market Trends
- 12.1.1.2 Market Forecast
- 12.1.2 Canada
- 12.1.2.1 Market Trends
- 12.1.2.2 Market Forecast
- 12.1.1 United States
- 12.2 Asia-Pacific
- 12.2.1 China
- 12.2.1.1 Market Trends
- 12.2.1.2 Market Forecast
- 12.2.2 Japan
- 12.2.2.1 Market Trends
- 12.2.2.2 Market Forecast
- 12.2.3 India
- 12.2.3.1 Market Trends
- 12.2.3.2 Market Forecast
- 12.2.4 South Korea
- 12.2.4.1 Market Trends
- 12.2.4.2 Market Forecast
- 12.2.5 Australia
- 12.2.5.1 Market Trends
- 12.2.5.2 Market Forecast
- 12.2.6 Indonesia
- 12.2.6.1 Market Trends
- 12.2.6.2 Market Forecast
- 12.2.7 Others
- 12.2.7.1 Market Trends
- 12.2.7.2 Market Forecast
- 12.2.1 China
- 12.3 Europe
- 12.3.1 Germany
- 12.3.1.1 Market Trends
- 12.3.1.2 Market Forecast
- 12.3.2 France
- 12.3.2.1 Market Trends
- 12.3.2.2 Market Forecast
- 12.3.3 United Kingdom
- 12.3.3.1 Market Trends
- 12.3.3.2 Market Forecast
- 12.3.4 Italy
- 12.3.4.1 Market Trends
- 12.3.4.2 Market Forecast
- 12.3.5 Spain
- 12.3.5.1 Market Trends
- 12.3.5.2 Market Forecast
- 12.3.6 Russia
- 12.3.6.1 Market Trends
- 12.3.6.2 Market Forecast
- 12.3.7 Others
- 12.3.7.1 Market Trends
- 12.3.7.2 Market Forecast
- 12.3.1 Germany
- 12.4 Latin America
- 12.4.1 Brazil
- 12.4.1.1 Market Trends
- 12.4.1.2 Market Forecast
- 12.4.2 Mexico
- 12.4.2.1 Market Trends
- 12.4.2.2 Market Forecast
- 12.4.3 Others
- 12.4.3.1 Market Trends
- 12.4.3.2 Market Forecast
- 12.4.1 Brazil
- 12.5 Middle East and Africa
- 12.5.1 Market Trends
- 12.5.2 Market Breakup by Country
- 12.5.3 Market Forecast
13 Drivers, Restraints, and Opportunities
- 13.1 Overview
- 13.2 Drivers
- 13.3 Restraints
- 13.4 Opportunities
14 Value Chain Analysis
15 Porters Five Forces Analysis
- 15.1 Overview
- 15.2 Bargaining Power of Buyers
- 15.3 Bargaining Power of Suppliers
- 15.4 Degree of Competition
- 15.5 Threat of New Entrants
- 15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
- 17.1 Market Structure
- 17.2 Key Players
- 17.3 Profiles of Key Players
- 17.3.1 Altimate Healthcare
- 17.3.1.1 Company Overview
- 17.3.1.2 Product Portfolio
- 17.3.2 Alto Nanoscience
- 17.3.2.1 Company Overview
- 17.3.2.2 Product Portfolio
- 17.3.3 ATAI Life Sciences N.V.
- 17.3.3.1 Company Overview
- 17.3.3.2 Product Portfolio
- 17.3.4 Fulgent Genetics Inc.
- 17.3.4.1 Company Overview
- 17.3.4.2 Product Portfolio
- 17.3.5 Invitae Corporation
- 17.3.5.1 Company Overview
- 17.3.5.2 Product Portfolio
- 17.3.6 Myriad Genetics Inc.
- 17.3.6.1 Company Overview
- 17.3.6.2 Product Portfolio
- 17.3.7 Precision Psychiatric Services Inc.
- 17.3.7.1 Company Overview
- 17.3.7.2 Product Portfolio
- 17.3.8 Tempus Labs Inc.
- 17.3.8.1 Company Overview
- 17.3.8.2 Product Portfolio
- 17.3.1 Altimate Healthcare
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
- Figure 1: Global: Precision Psychiatry Market: Major Drivers and Challenges
- Figure 2: Global: Precision Psychiatry Market: Sales Value (in Million US$), 2018-2023
- Figure 3: Global: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: Global: Precision Psychiatry Market: Breakup by Product Type (in %), 2023
- Figure 5: Global: Precision Psychiatry Market: Breakup by Sample (in %), 2023
- Figure 6: Global: Precision Psychiatry Market: Breakup by Biomarker Type (in %), 2023
- Figure 7: Global: Precision Psychiatry Market: Breakup by Technology (in %), 2023
- Figure 8: Global: Precision Psychiatry Market: Breakup by Application (in %), 2023
- Figure 9: Global: Precision Psychiatry Market: Breakup by End User (in %), 2023
- Figure 10: Global: Precision Psychiatry Market: Breakup by Region (in %), 2023
- Figure 11: Global: Precision Psychiatry (Products) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Precision Psychiatry (Products) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Precision Psychiatry (Services) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Precision Psychiatry (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Precision Psychiatry (Blood-Based) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Precision Psychiatry (Blood-Based) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Precision Psychiatry (Non-Blood-Based) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Precision Psychiatry (Non-Blood-Based) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Precision Psychiatry (Genetic Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Precision Psychiatry (Genetic Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Precision Psychiatry (Protein Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Precision Psychiatry (Protein Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Precision Psychiatry (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Precision Psychiatry (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Precision Psychiatry (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Precision Psychiatry (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Precision Psychiatry (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Precision Psychiatry (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Precision Psychiatry (Immunoassay) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Precision Psychiatry (Immunoassay) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Precision Psychiatry (Liquid Chromatography-Mass Spectrometry (LC-MS)) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Precision Psychiatry (Liquid Chromatography-Mass Spectrometry (LC-MS)) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Precision Psychiatry (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Precision Psychiatry (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Precision Psychiatry (Alzheimer's Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Precision Psychiatry (Alzheimer's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Global: Precision Psychiatry (Parkinson's Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Global: Precision Psychiatry (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Global: Precision Psychiatry (Autism) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Global: Precision Psychiatry (Autism) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Global: Precision Psychiatry (Depression) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Global: Precision Psychiatry (Depression) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Global: Precision Psychiatry (Bipolar Disease) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Global: Precision Psychiatry (Bipolar Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Global: Precision Psychiatry (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Global: Precision Psychiatry (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Global: Precision Psychiatry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Global: Precision Psychiatry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Global: Precision Psychiatry (Academic and Research Institutions) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Global: Precision Psychiatry (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Global: Precision Psychiatry (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Global: Precision Psychiatry (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: North America: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: North America: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: United States: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: United States: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Canada: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Canada: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Asia-Pacific: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Asia-Pacific: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: China: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: China: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Japan: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Japan: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: India: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: India: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: South Korea: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: South Korea: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Australia: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Australia: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Indonesia: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Indonesia: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Others: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Others: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Europe: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Europe: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Germany: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Germany: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: France: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: France: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: United Kingdom: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: United Kingdom: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: Italy: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: Italy: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: Spain: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 86: Spain: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 87: Russia: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 88: Russia: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 89: Others: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 90: Others: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 91: Latin America: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 92: Latin America: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 93: Brazil: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 94: Brazil: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 95: Mexico: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 96: Mexico: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 97: Others: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 98: Others: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 99: Middle East and Africa: Precision Psychiatry Market: Sales Value (in Million US$), 2018 & 2023
- Figure 100: Middle East and Africa: Precision Psychiatry Market: Breakup by Country (in %), 2023
- Figure 101: Middle East and Africa: Precision Psychiatry Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 102: Global: Precision Psychiatry Industry: Drivers, Restraints, and Opportunities
- Figure 103: Global: Precision Psychiatry Industry: Value Chain Analysis
- Figure 104: Global: Precision Psychiatry Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Precision Psychiatry Market: Key Industry Highlights, 2023 & 2032
- Table 2: Global: Precision Psychiatry Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
- Table 3: Global: Precision Psychiatry Market Forecast: Breakup by Sample (in Million US$), 2024-2032
- Table 4: Global: Precision Psychiatry Market Forecast: Breakup by Biomarker Type (in Million US$), 2024-2032
- Table 5: Global: Precision Psychiatry Market Forecast: Breakup by Technology (in Million US$), 2024-2032
- Table 6: Global: Precision Psychiatry Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 7: Global: Precision Psychiatry Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 8: Global: Precision Psychiatry Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 9: Global: Precision Psychiatry Market: Competitive Structure
- Table 10: Global: Precision Psychiatry Market: Key Players
